Clinical Trial Update: A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea

View source ↗

Summary

This document reports an ongoing post-marketing surveillance study in Korea to evaluate the safety of Ozanimod for adults with moderate to severe active ulcerat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Zeposia (ozanimod hydrochloride)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Ulcerative Colitis | Status: RECRUITING